Josh Barro

In this engaging discussion, economics journalist Michael Tukjer sheds light on how Novo Nordisk's weight-loss drug, Ozempic, is a financial powerhouse for Denmark. Writer Josh Barrow dives into Ozempic's booming popularity and its profound societal impacts. They explore the economic dependency of cities revitalized by job creation from the pharmaceutical giant. The conversation also touches on the changing dynamics of consumer behavior and the potential future of obesity treatment in America, as these drugs reshape the healthcare landscape.

Josh Barro, a contributor to 'Very Serious,' dives into the complexities of political slogans and their different meanings across party lines. Megan McArdle from The Washington Post examines the shift in public trust toward universities and scientific research, especially post-COVID-19. Writer Ben Dreyfuss adds commentary on the growing polarization in politics and academia, emphasizing the need for unity in diversity of thought. They also touch on the implications of recent controversies in government and the critical role of inclusivity in political discourse.